Neuralgia Treatment Market Global Industry Analysis and Research Report 2020

 The global neuralgia treatment market size is predicted to reach USD 2.83 billion by 2027 according to a new study by Polaris Market Research. The report “Neuralgia Treatment Market Size, Share & Trends Analysis Report, By Treatment (Drug Based [Anticonvulsant Medicines, Tricyclic Antidepressants], Surgeries [Balloon Compression, Glycerol Injection, Radiofrequency Thermal Lesioning, Stereotactic Radiosurgery, Microvascular Decompression]); By End-Use; By Region, And Segment Forecasts, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The neuralgia treatment market is expected to witness significant growth owing to the increasing incidences of diabetes and trigeminal neuralgia. Furthermore, multiple sclerosis is also one of factors which can cause neuralgia. Multiple sclerosis decreases the body immunity owing to the neurodegenerative condition which affects the myelin sheath that can cause neuralgia. This is likely to drive market demand over the forecast period.

 

The potential drug candidates and the expected drug approval is expected to stimulate the global market, with high concentration of pharmaceutical companies engaged in the research & development of novel drugs for neuralgia treatment. For instance, U.S-based drug manufacturer, Biogen Inc. is developing BIIB074 (Vixotrigine) for the treatment of trigeminal neuralgia and is currently in phase II.

 

Download Sample Copy https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/request-for-sample

 

Market participants such as Allergan Plc, GlaxoSmithKline Plc., Biogen, Inc., Abbott Laboratories, PixarBio Corporation, Merz Pharma GmbH, Trigemina Inc., Pfizer Inc., Novartis, Lupin, and others. are some of the key players operating in the global market. Biohaven pharmaceuticals has Rimegepant in the phase II clinical trials and it is estimated to be completed by December 2020. The drug is a potent antagonist of the CGRP receptor. The receptor is responsible for neural sensitization and neuropathic pain.

 

In May 2020, CODA Biotherapeutics, Inc. (CODA), the U.S.-based clinical stage pharmaceutical company currently in the process of developing gene therapy based chemogenetic platform announced the collaboration with the Facial Pain Research Foundation (FPRF) to utilize company’s proprietary platform to develop potential therapies and treatment options for the trigeminal neuralgia and other neurological conditions.

 

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/speak-to-analyst

 

 

Polaris Market Research has segmented the neuralgia treatment market report on the basis of treatment, indication, distribution channel, and region

 

Neuralgia Treatment, By Treatment (Revenue – USD Million, 2016 – 2027)

• Drug Based
  • Anticonvulsant Medicines
    • Carbamazepine
    • Oxcarbazepine
    • Topiramate
    • Gabapentin
    • Pregabalin
    • Clonazepam
    • Phenytoin
    • Lamotrigine
    • Valproic Acid
  • Tricyclic Antidepressants
    • Amitriptyline
    • Nortriptyline
• Surgeries
  • Balloon Compression
  • Glycerol Injection
  • Radiofrequency Thermal Lesioning
  • Stereotactic Radiosurgery
  • Microvascular Decompression

Neuralgia Treatment, By End-Use (Revenue – USD Million, 2016 – 2027)

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Neuralgia Treatment, By Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Read More : https://www.medgadget.com/2021/02/neuralgia-treatment-market-size-worth-2-83-billion-by-2027-exclusive-study-by-polaris-market-research.html

Rapid Oral Fluid Screening Device Market Global Industry Analysis and Research Report 2020

 The global rapid oral fluid screening device market size is predicted to reach USD 24.08 billion by 2027 according to a new study by Polaris Market Research. The report “Rapid Oral Fluid Screening Device Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Alcohol, Marijuana, Opioids, Cocaine, Amphetamine, Methamphetamine, Benzodiazepines); By Forms (Cassettes, Swabs, Strips); By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Private Employers, Home care Setting); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

In trend with the developing business models in healthcare sector, development of effective, efficient and productive products is on a significant surge, coupling with increasing favorable reimbursements and approvals by the government. Rising strong product pipelines for the research & development of novel rapid oral fluid screening devices also contribute a remarkable proportion towards surging the market growth globally over the forecast period.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-sample

 

Furthermore, as the technology is becoming easy-to-develop and subject to a smaller number of regulations, the market is witnessing less entry hurdles for new entrants. Additionally, rapid oral fluid has ability to diagnose drug consumed in the body in less than one day and cannabis consumed in less than four hours after the testing time, hence, propelling the growth of rapid oral fluid screening devices, globally over the projected period.

 

Rapid oral fluid screening devices provide a wide range of screening abilities such as marijuana, cocaine, methamphetamine, and opioids are expected to drive rapid oral fluid screening device market growth over the forecast period. In addition, the growing need for drug screening across the regions owing to increasing consumption of illegal narcotics is expected to drive the demand for these devices in the coming years.

 

Get Discount on this Research Report : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-discount-pricing

 

The global rapid oral fluid screening device market players include OraSure Technologies, Inc., Oranoxis Inc., Guangzhou Wondfo Biotech Co., Ltd, UCP Biosciences, Inc., MEDACX Limited, Screen Italia Srl, and AccuBioTech Co. Ltd., among others. Moreover, developing and commercializing products that evaluate adherence to HIV medications, enhancing its product offerings to include additional diagnostic offerings, and building new infrastructure also adds towards the growth of the organizations.

 

Read More : https://www.prnewswire.com/news-releases/rapid-oral-fluid-screening-device-market-size-usd-24-08-billion-by-2027--cagr-20-7--polaris-market-research-301212427.html

Architectural Coatings Market 2021 | Industry Analysis | Global and Regional Market Forecast to 2028

 The global architectural coatings market size is expected to reach USD 99.03 billion by 2027 according to a new study by Polaris Market Research. The report “Architectural Coatings Market Share, Size, Trends, Industry Analysis Report, By Resin Type (Acrylics, Alkyds, Epoxy, Urethanes, Vinyl, Others); By Technology (Water-borne, Solvent-borne, Powder); By Application (Residential, Non-Residential); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The demand for architectural coatings is expected to witness growth on account of increasing demand in the residential and non-residential sectors. In addition, technological advancement in the field of coatings and development of green products is expected to drive the demand for architectural coatings across the globe. Furthermore, increasing construction projects in Asia Pacific countries such as China and India are likely to complement market growth.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/architectural-coatings-market/request-for-sample

 

Several traditional solvent-based architectural coatings owing to presence of high levels of Volatile Organic Compounds (VOCs) are losing popularity in the coatings industry. On account of the wide range of advantages of solvent-based coatings such as liquefying properties, increased evaporation rates, and reduced drying time, solvent-based coatings are being used in a variety of industrial applications. Water-borne coatings are gaining popularity on account of eco-friendly nature of the coatings.

 

Increasing levels of emission of Hazardous Air Pollutants (HAPs) and Volatile Organic Compounds (VOCs) from conventional solvent-based coatings have raised concerns pertaining to environmental degradation. The government across the globe are restricting the usage of toxic and harmful coatings. With enactment of stricter laws and regulations to curb air pollution caused due to hazardous emissions and conventional solvent-based coatings are likely to be soon replaced by green- or bio-based solvents. In order to comply with the laws and regulations, consumers are increasingly opting for green coatings.

 

Market participants such as PPG Industries, Inc., Akzo Nobel N.V., The Sherwin-Williams Company, Kansai Paints Co., Ltd., Asian Paints Limited, and Nippon Paint Holdings Co., Ltd., BASF SE, Masco Corporation, Jotun Group, and RPM International Inc. are some of the key players operating in the concerned market. The research scholars at the premier IIT Hyderabad are using fly ash to form water repellent structure. These hydrophobic structures can be used as anti-soiling coatings, stainless textiles, self-cleaning coatings, and anti-sticking surfaces for the antennae.

 

Any Question! ask our industry expert : https://www.polarismarketresearch.com/industry-analysis/architectural-coatings-market/speak-to-analyst

 

Automotive Wholesale and Distribution Aftermarket Revenue And Growth Rate 2021-2027

 The worldwide Automotive Wholesale And Distribution Aftermarket Market is anticipated to reach over USD 295.2 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the passenger vehicles segment dominated the global market, in terms of revenue. In 2017, North America accounted for the majority share in the global automotive wholesale and distribution aftermarket market.

 

The expanding global automotive industry, along with increasing average age of vehicles majorly drives the automotive wholesale and distribution aftermarket market growth. The increasing sale of passenger vehicles, especially form the emerging economies of Asia-Pacific, and use of advanced technology for fabrication of auto parts boosts the market growth.

 

Sample Copy of Report @ https://www.polarismarketresearch.com/industry-analysis/automotive-wholesale-and-distribution-aftermarket-market/request-for-sample

 

Consumers are increasingly becoming aware of proper maintenance and repair of vehicles, which supports market growth. Other factors driving market growth include greater need for long distance travel, technological advancements in telematics technologies, and changing lifestyles. New emerging markets, and emerging consumer demographics would provide growth opportunities for automotive wholesale and distribution aftermarket market in the coming years.

 

In 2017, North America accounted for the highest share in the global automotive wholesale and distribution aftermarket market. The established automotive industry, technological advancements, and high investment in R&D are factors expected to drive the market growth in the region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period. This is due to economic growth in countries such as China and India, leading to rising living standards and increasing disposable income. Expansion of global players into these countries to tap market potential boosts the market growth. Favorable regulations for production of automotive wholesale and distribution aftermarket components, and poor road infrastructure in developing countries such as India, and Pakistan are expected to augment Automotive Wholesale And Distribution Aftermarket Market Growth during the forecast period.

 

Get Discount Offer @  https://www.polarismarketresearch.com/industry-analysis/automotive-wholesale-and-distribution-aftermarket-market/request-for-discount-pricing

 

The companies operating in the market include Denso Corporation, Robert Bosch GmbH, ZF Friedrichshafen AG, Continental AG, 3M Company, Delphi Automotive PLC, Magneti Marelli S.p.A, Goodyear Tire & Rubber Company, Cooper Tire & Rubber Company, and Federal-Mogul Corporation. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Intravenous Immunoglobulin Market Latest Trends To Boost Industry Growth

 The global intravenous immunoglobulin market size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research published by Polaris Market Research 

 

Immunoglobulins (IGs) are glycoproteins that are formed in the blood plasma in response to the antigens (Ag), which are considered as a foreign material to the host system. IGs are highly composite objects and precise in their nature. They are achieved from blood by fractionation procedure and filtered fo non-therapeutic as well as therapeutic applications. In therapeutics, they are administered intravenously for the treatment of several immunodeficiency.

 

The global intravenous immunoglobulin market majorly is driven by rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others. 

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

 

 

Moreover, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from PID globally. Rising occurrences of these immune diseases is anticipated to bolster the demand for intravenous immunoglobulin treatments during the forecast period. The demand for IVIG treatments for the primary and acquired immunodeficiency disorder is growing as it is the only available as well as most effective treatment option. Moreover, inactive lifestyle behaviors, including intake of saturated fats, sugars and salts, less physical actions, and high alcohol intake have led to the surge in the occurrence of such diseases. Increasing occurrence of such lifestyle related disease including antibody deficiency disorders and obesity are the factors anticipated to drive the global intravenous immunoglobulin market growth.

  

The global intravenous immunoglobulin market is segmented on the basis of Application and geography. On the basis of application, the global Intravenous Immunoglobulin Market is categorized into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP). In 2017, Hypogammaglobulinemia is estimated to dominate the application segment. The dominancy is attributed to the growing global occurrences of primary immunodeficiency diseases (PID). It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). According to the Centers for Disease Control and Prevention (CDC) in 2012, the global occurrence rate of hypogammaglobulinemia was around 2 per 100,000 populations moreover, the number of people suffering this type of disease are estimated to increase during the forecast period. Growing occurrence of immunodeficiency disorders associated with the high implementation of IVIG therapies is expected to drive the segment growth significantly.

 

Get Discount Offer: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-discount-pricing

 

 

Some major key players in global intravenous immunoglobulin market include Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare among others.

Technical textiles Market Rising At Rapid Growth Rate During 2021-2027

 The global technical textiles market is anticipated to reach USD 14.93 billion by 2026 according to a new study published by Polaris Market Research

 

The primary driving factors for the global market includes the increasing consumer profiles along with income levels, rising end user sectors such as automobiles, sports, healthcare etc. The overall industrial and infrastructure development in the emerging and developed nations are yet other potential reasons for the market growth. Moreover, the initiatives from several governments and other regulatory bodies in attracting substantial investments in development of novel technical textile product are also anticipated to drive the industry growth. These products represent mainly a next generation of smart textiles with potential use in various fashion products, technical textiles and furnishing applications. The basic notion of these smart textiles consists of the textile structures that senses and also reacts to various stimuli from the environment. The market expansion of these products is owing to the new textile fiber types and its structure, miniaturization of the electronics and also wireless & wearable technologies.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/technical-textiles-market/request-for-sample

 

The technical textiles include around 51 potential products for high growth that accounted for over 25% of industry size in 2017. A few of these include mulch mats, shade nets, anti-hail, crop covers, anti-bird nets, incontinence diaper, baby diapers, sanitary napkins, surgical disposables, artificial heart valves, bullet proof jackets, disposable bed sheets, nuclear protective clothing, chemical protective clothing, industrial clothing etc. These products represent multi-disciplinary segments with several application sectors. Advancements in functionality of technical fibers and yarns including low elongation at break high tenacity, low thermal shrinkage, high modulus, high resistance to corrosion, higher thermal stability etc. which were the outcome of significant investments in R&D by industry participants have been helpful in increasing its applications in numerous industries.

 

 

Some of the leading industry participants currently operating in the industry include DuPont De Nemours & Co., Royal Ten Cate, Johns Manville, Ahlstrom Corporation, GSE Environmental Inc., Proctor and Gamble, Freudenberg & Co., Hindustan Technical Fabrics Limited, Huesker Synthetic GmbH and 3M.

 

If you have any special requirements, please let us know and we will offer you the report as you want. Place your Quiry Here! https://www.polarismarketresearch.com/industry-analysis/technical-textiles-market/speak-to-analyst

 

North America was the leading regional market in 2017. Along with increasing penetration of these products, consumption of technical textiles is increasing, and several nations cater to their demand by mainly importing these smart textiles from the U.S. The primary export markets of the U.S. include India, Vietnam, Brazil and Taiwan. Taiwan and Korea have emerged as a potentially powerful competitor to the US. The Asia Pacific market is projected to grow at a faster rate compared to other regions.

Electric Power Distribution Automation Systems Market Latest Trends To Boost Industry Growth

 The Electric Power Distribution Automation Systems Market is anticipated to reach around USD 23.8 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the industrial segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue during the forecast period. 

 

The growing adoption of smart cities, along with high demand of smart grids has boosted the adoption of electric power distribution automation systems. The rising demand for electricity, and growing demand for efficient and low-cost solutions for efficient power distribution further support the growth of electric power distribution automation systems market. Increasing investments by vendors in technological advancements, growing need to update existing networks, and increasing ageing infrastructure would accelerate the adoption of electric power distribution automation systems during the forecast period. Growing demand from emerging economies, increasing adoption smart grid applications, and technological advancements are expected to provide numerous growth opportunities in the coming years.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/electric-power-distribution-automation-systems-market/request-for-sample

 

North America generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The presence of established telecom and cloud infrastructure in this region, and growing trend of smart cities drive the market growth in the region. The growing demand from energy sector, and technological advancements further support market growth in the region. The use of smart technologies in energy and utilities, investments in transmission and distribution infrastructure, and increasing ageing infrastructure is expected to support market growth in this region during the forecast period.

 

The companies operating in the market include General Electric, Eaton Corporation Plc, Mitsubishi Electric Corp., ABB Ltd., G&W Electric Company, Schneider Electric, Elster Solutions, Schweitzer Engineering Laboratories, Siemens AG, and S&C Electric Company. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/electric-power-distribution-automation-systems-market/request-for-discount-pricing

 

Caprolactam Market Revenue And Growth Rate 2021-2027

 The global caprolactam market size is anticipated to reach USD 28.2 billion by 2026 according to a new research published by Polaris Market Research. The report “Caprolactam Market Share, Size, Trends, Industry Analysis Report, By End-Product (Nylon 6 Resins, Nylon 6 Fibers, and Others); By Application (Industrial Yarns, Engineering Resins & Films, Textiles & Carpets, and Others); By End-Use (Textile, Carpet, Automotive, and Others), By Regions, Segments & Forecast, 2019 – 2026” provides detailed insight on current market growth indices and future market trends.

 

Caprolactam is a major raw material for the production of nylon 6 engineering resins and nylon 6 fibers. This market is primarily driven by end- use industries such as automobiles, textiles, electrical and electronics, engineering plastics, specialty film packaging, wire and cabling and others. A rising demand for plastics in the construction, automotive and electrical and electronics sectors is expected to be key enabler to growth over forecast period.

 

Key properties including high strength, elasticity, abrasion resistance and low moisture retaining capacity is expected to boost demand. The soaring textile industry, particularly in Asia Pacific in line with growing automobile sector is expected to project demand over the forecast period.

 

Automobile industry is the industry of choice in demand for Caprolactam. Automobile industry makes use of Caprolactam in engine covers, tire cord manufacture, and gears and bearings due to their attractive properties.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/caprolactam-market/request-for-sample

 

The growth in Caprolactam has made an impact due to rapidly growing sportswear, fashion clothing, protective clothing and others. Nylon 6 fibers are used in manufacturing textile products and industrial yarn. Nylon 6 fibers are derived from Caprolactam.

 

An expanding populace coupled with growing personal incomes of consumers has seen textile and automobile industry witness extraordinary growth. Electric vehicles having entered the market has soared consumer expectations. The strong economic indices of many middle-income countries in the world have rapidly driven demand for high product among consumers. The product is made from ammonia, cyclohexane and phenol. As these materials are petro chemically derived, the product might be subject to price volatility. The raw materials are mainly located in China and the U.S. The countries drive growth in Caprolactam market because of increasing presence of oil refineries in the countries. The year 2016 saw major price fluctuations due to pricing of raw material benzene and derivatives and restricted supply.

 

Caprolactam includes two major end-use products, nylon 6 fibers and nylon 6 resins. Nylon 6 fiber is used preferentially in carpets, industrial yarns and textile industries and Nylon 6 resins finds its way in specialty films packaging, engineering plastics, wires and cables and automotive industries.

 

China is the major consumer of Caprolactam globally amidst Asia Pacific region that has grown to be the fast-regional player. This happens due to excess capacity derived in China and immediate developments in automobile, textile and plastic industries. Substantial product is discovered in Asia pacific region such as Taiwan, South Korea, Japan, India and SE Asia. Caprolactam finds application in various end-use industries including textile yarn, industrial yarn, engineering plastics, carpet fibers and staple fibers.

 

Get Offer : https://www.polarismarketresearch.com/industry-analysis/caprolactam-market/request-for-discount-pricing

 

The location of manufacturers across the value chain is justified with product demand coming from presence of Nylon 6 fibers and resins in various end-use applications. A dominant share of Caprolactam manufactured is used in manufacture of nylon 6. Technical innovations improve the market by reducing presence of ammonium sulphate which is an environment hazard. This results in positive demand for the product.

 

The global cparolactum market comprises major international and domestic market players. Some of the key companies include BASF SE, China National Petrochemical Corp., DOMO Caproleuna GmbH, Honeywell Chemical Industries, China Petroleum and Chemical Corp, Royal DSM NV and IRPC Public Company Ltd.

 

COVID-19 Sample Collection Kits Market Rising At Rapid Growth Rate During 2021-2028

 The global COVID-19 sample collection kits market size is expected to reach USD 16.56 billion by 2028 according to a new study by Polaris Market Research. The report “COVID-19 Sample Collection Kits Market Share, Size, Trends, Industry Analysis Report, By Product (Swabs, Viral Transport Media, Blood Collection Kits, Others); By Application (Diagnostics, Research); By Collection Site (Hospitals & Clinics, Home Test), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Asia Pacific COVID-19 sample collection kits industry is expected to witness a lucrative growth rate over the assessment period. This is since, this pandemic tends to hit countries more severely, owing to its fragile and underfunded healthcare systems, as there is a disparity between need and purchasing power capacity for preventive measures.

 

Countries in the region actively engaged in containing COVID-19 infection spread. For instance, in November 2020, ICMR introduced an ambulatory covid-19 RT-PCR lab at its facility. The government has also announced to establish more labs to boost COVID-19 testing.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/covid-19-sample-collection-kits-market/request-for-sample

 

 

In 2020, the swabs COVID-19 sample kits industry segment accounted for the largest share. This high share is attributed to the reliance on several approved diagnostic products on the use of nasopharyngeal swabs. As per CDC, samples could also be collected from the respiratory tract, when the use of nasopharyngeal swabs is not sufficient.

 

Key players in the market for COVID-19 sample collection kits are employing several market strategies to accelerate the supply of products for coronavirus sampling. In line with this, in November 2020, Puritan has received funding of more than USD 11.6 million for the expansion of swab production to cater to the demand of around 3 million swabs in a month. The company has also received additional funding from Paycheck Protection Program.

 

However, the blood collection kits segment is projected to witness a lucrative market growth rate over the assessment period. Such growth is due to approvals in the blood-related detection tests. For instance, in November 2020, U.S.-based company AnPac Bio-Medical announced the approval of its EUA-antibody test by the FDA for Roche’s Elecsys Anti Sars-COV-2 test.

 

Get Discount on this Research report :  https://www.polarismarketresearch.com/industry-analysis/covid-19-sample-collection-kits-market/request-for-discount-pricing

 

COVID-19 sample collection kits industry participants such as Lucence Diagnostics Pte Ltd., Laboratory Corporation of America Holdings, Trinity Biotech, Puritan Medical Products, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., COPAN Diagnostics, Hardy Diagnostics, Quidel Corporation, Quest Diagnostics, Vitagene Inc., HiMedia Laboratories, and VIRCELL S.L. are some of the key players operating in the COVID-19 sample collection kits industry.

 

Players and organizations across the globe are developing innovative products for sample collection. In line with this, in January 2021, the India-based, Defence Research, and Development Organization (DRDO) introduced COVSACK, a sample collection kiosk for the health practitioners to collect samples, without any need of PPE kits.

 

Read More : 

https://www.prnewswire.com/news-releases/covid-19-sample-collection-kits-market-size-worth-16-56-billion-by-2028--cagr-2-3--polaris-market-research-301248079.html

 

https://www.medgadget.com/2021/03/covid-19-sample-collection-kits-market-size-is-projected-to-reach-16-56-billion-by-2028-polaris-market-research.html

 

https://currently.att.yahoo.com/att/covid-19-sample-collection-kits-123000523.html

 

 

Blood Cancer Drugs Market Trends Report | SWOT Analysis | 2020-2026

 The global blood cancer drugs market is anticipated to reach USD 55.6 billion by 2025 according to a new report published by Polaris Market Research. The report ‘Blood Cancer Drugs Market [By Blood Cancer Type (Leukemia (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia), Lymphoma (Hodgkin Lymphoma, Non-Hodgkin Lymphoma (B-Cell Lymphoma, T-Cell Lymphoma)), and Myeloma; By Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others); By Treatment Approaches (Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic); By Region]: Market Size & Forecast, 2017 – 2025’ provides insights on the current market scenario and the future prospects.

 

The demand for blood cancer drug is primarily driven by growing death incidences by blood cancer, and continuous innovation for developing novel treatments with the help of several ongoing clinical trials. Moreover, increasing research and development of biological and targeted therapies as treatment will spur the blood cancer drugs market during the upcoming period. However, the high price of drugs and the stringent government policies will limit the growth of blood cancer drugs market during the forecast period.

 

Most of the blood cancers start in the bone marrow, where blood is produced. In blood cancer the growth of normal blood cells is dislodged by the uncontrollable growth of abnormal blood cells. These cancerous cells prevent the blood from performing many of its functions. Hence, the existing treatments of blood cancer are being the foundation for developing the new drugs. The steady flow of the blood cancer drugs has created opportunity for research and development in the existing market. For instance, Amgen Inc. received approval for BLINCYTO in July 2017, which is used in treating B-cell precursor Acute Lymphoblastic leukemia. Similarly, European blood cancer drugs market witnessed the approvals of Gazyvaro, by Roche AG that is used in treating advanced follicular lymphoma. Also, novel technologies like CAR-T are likely to be launched this year.

 

Download Sample copy :  https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/request-for-sample

 

The global blood cancer drugs market is segmented into blood cancer type, drugs and treatment approaches. On the basis of blood cancer type, the global blood cancer drugs market is segmented into leukemia, lymphoma and myeloma. The lymphoma segment is expected to drive the majority market of blood cancer drugs followed by leukemia. The global market of this segment is primarily driven by the increasing prevalence of lymphoma, and presence of effective treatments in the market. On the basis of drugs, the global blood cancer drugs market is further categorized into Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others. This continuous innovation for treating various sub-types of blood cancers has led to the development of novel types of treatments. For instance, the combination of Revlimid and Velcade has emerged as the preferential drugs in trials for treating multiple myeloma.

 

 

On the basis of treatment approaches the global blood cancer drugs market is further segmented into Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic. Due to availability of variety of chemotherapeutic agent in the market chemotherapeutic drugs are expected to hold the higher share in blood cancer drugs market. Moreover, their effectiveness for the treatment of blood cancer and increasing number of cancer patients globally has garnered more demand for chemotherapeutic drugs throughout the world.

 

Geographically, the global blood cancer drugs market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominates the blood cancer drugs market which is followed by Europe and Asia Pacific. Favorable reimbursement policies, surge in R&D investments of various companies, as well as the increase in the number of blood cancer treatments are some of the major factors responsible for the growth of North America’s blood cancer drugs market. Moreover, Asia-Pacific region has been identified as the lucrative market for the for blood cancer drugs due to increasing awareness of the use of these drugs, increased healthcare expenditure, and rising per capita disposable income. These are some of the major factors which are influencing the growth of the blood cancer drugs in Asia-pacific region. 

 

Have Questions? make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/request-for-discount-pricing

 

The leading companies operating in this industry include Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer, Inc., AbbVie Inc., Roche Holding AG., Celgene Corporation, AstraZeneca, Novartis AG, GlaxoSmithKline PLC, Merck & Co., Inc., and Eli Lily & Co. among others.

 

Key Findings from the study suggest blood cancer drugs in the market are much innovative and manufacturers are progressively concentrating on innovation of combination drugs. Companies are in a stage of development of new drugs in order to provide novel treatments for blood cancer. The immunotherapy segment is anticipated to grow at a high growth rate over the forecast period. The growth of this segment is primarily driven by increased awareness for its use as an alternative and effective treatment for blood cancer. North America is presumed to dominate the global blood cancer drugs market over the forecast period. Asia Pacific region which shows signs of high growth potential owing to the booming economies of India, and China.

 

Battery Market Trends Report | SWOT Analysis | 2020-2026

 The global Battery Market is anticipated to grow at a CAGR of 11.3% from 2020 to 2026 according to a new research published by Polaris Market Research. In 2019, the consumer electronics segment accounted for the highest market share in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global Battery market revenue in 2019.

 

The demand for smartphones and other mobile devices is increasing worldwide, promoting the growth of the Battery market. The growing use of batteries in varied industries such as aerospace and defense, healthcare, and electronics has accelerated the battery market growth. Increasing disposable incomes in developing countries, rising living standards, and growing environmental concerns foster the Battery market growth. The demand for battery electric vehicles has increased significantly over the years owing to increasing prices of gasoline across the globe, resulting in increased adoption of batteries. The exponential growth in the prices of gasoline and diesel owing to the depleting fossil fuel reserves has encouraged consumers to switch to battery electric vehicles, thereby supporting the battery market growth. Leading global players are expanding their presence in developing nations of China, japan, India, Indonesia, and Malaysia to tap the battery market growth opportunities offered by these countries.

 

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/battery-market/request-for-sample

 

There has been a significant reduction in the prices of Li-ion batteries over the years, which drives the growth of the battery market. Most electric vehicles are equipped with Li-ion batteries. The prices of lithium-ion batteries have fallen by nearly half since 2014. Declining battery prices in turn result in lower prices of battery electric vehicles. According to the Institute for Energy Research, the cost of a Tesla battery pack in the current scenario is $190 per kWh. It is predicted that the cost would reach $100 per kWh by 2020, significantly increasing the market share of battery electric vehicles as well. The increasing production volume of batteries, and increasing adoption of batteries in electric vehicles and hybrid electric vehicles have resulted in reduced costs of batteries.

 

Asia-Pacific generated the highest Battery market revenue in 2019, and is expected to lead the global Battery market throughout the forecast period. The growing population, rising disposable incomes, and increasing penetration of mobile devices has increased the Battery market growth in the region. The increasing demand of batteries from industries such as healthcare, automotive, electronics, and defense among others, coupled with growing acceptance of green technology and electric vehicles drives the Battery market growth in the region.

 

The well-known companies profiled in the Battery market report include BYD Company Limited, Duracell, Eveready Industries, Johnson Controls, Exide Technologies, LG Chem Limited, Sony Corporation, NEC Corporation, Panasonic Corporation, Toshiba Corporation, Samsung SDI Company Limited, and EnerSys. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

If you have any query regarding the report, ask our experts: @ https://www.polarismarketresearch.com/industry-analysis/battery-market/speak-to-analyst